FDA Adverse Event Injury Summary report: N

CYPHER SIROLIMUS-ELUTING CORONARY STENT

MDR report key: 1033587 · Received April 23, 2008

Report

Report Number
9616099-2008-01078
Event Type
Injury
Date Received
April 23, 2008
Date of Event
October 10, 2007
Report Date
March 28, 2008
Manufacturer
CORDIS DE MEXICO
Product Code
NIQ
PMA / PMN Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS PROD IS DISTRIBUTED OUTSIDE THE US. HOWEVER, IT IS SIMILAR TO THE US DISTRIBUTED DRUG-ELUTING STENTS. THIS IS ONE OF TWO PRODUCTS INVOLVED WITH THE REPORTED EVENT. THE ASSOCIATED MFR REPORT NUMBER IS 9616099-2008-01079. ADD'L INFO WILL BE SUBMITTED WITHIN 30 DAYS OF RECEIPT.

Description of Event or Problem · 1

A MONTH POST-PROCEDURE, THE PT UNDERWENT A RE-PCI. IT IS UNK WHAT VESSEL WAS INVOLVED IN THE RE-PCI, THEREFORE, THIS WILL BE REPORTED AS A CORONARY RESTENOSIS. APPROX 2 MONTHS POST-PROCEDURE, THE PT EXPERIENCED NON-CARDIAC CHEST PAIN. THE REPORT IS FROM THE STUDY. THE PT WAS A MALE WITH 2-VESSEL DISEASE. ONE LESION WAS TREATED DURING THE INDEX PROCEDURE AND A STAGED PROCEDURE WAS PLANNED DUE TO TIME OR LOGISTICS. THE PT HAD A HISTORY OF OBESITY, HYPERTENSION, HYPERLIPIDEMIA, AND SMOKING. THE INDICATION FOR THE INDEX PROCEDURE WAS UNSTABLE ANGINA PECTORIS. THE TARGET LESION WAS THE MID TO DISTAL RIGHT CORONARY ARTERY (RCA). VESSEL DIAMETER WAS 3MM AND THE LESION LENGTH WAS 50MM. PRE-PROCEDURE STENOSIS WAS 100%. THE LESION WAS DE NOVO AND A TOTAL OCCLUSION. THE LESION WAS PRE-DILATED WITH A 2.5 X 20MM BALLOON AT 18 ATMS. TWO STENTS WERE IMPLANTED OVERLAPPING IN THE LESION. A CYPER WAS DEPLOYED AT 14 ATMS AND ANOTHER CYPHER WAS DEPLOYED AT 16 ATMS. POST-PROCEDURE STENOSIS WAS 0%. THE PT WAS DISCHARGED THE FOLLOWING DAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CYPHER SIROLIMUS-ELUTING CORONARY STENT DRUG-ELUTING STENT (NIQ) NIQ CORDIS DE MEXICO NA 13243927

Patients

Seq Age Sex Outcome Treatment
1 61 YR Required Intervention DEVICES: 6FR GUIDING CATHETER| BETA BLOCKERS| ASPIRIN| CLOPIDOGREL| STATINS| 2.5 X 20 BALLOON| HEPARIN| MEDICATIONS: ACE INHIBITORS